Chemoprevention of keratinocyte carcinomas and actinic keratoses in adults who were immunocompetent: a systematic review.
- 2026-02-11
- Systematic Review · n = 7,355
- Clinical and experimental dermatology 51(7)
- Alyssa Susanto
- Emma Morgan
- Daniel Lindsay
- Louisa G Collins
- PubMed: 41671392
- DOI: 10.1093/ced/llag073
- High evidence
- Clinical
Nicotinamide reduced SCCs by 30% and AKs by 13-35% across two trials (P < 0.05).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes